Physician profile
Benjamin R Pace
NPI 1366853020
$2,622.97
in general payments reported to CMS, 2019-2025
18 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $386 · 2021: $292 · 2022: $372 · 2023: $520 · 2024: $319 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,270.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $842.05 | 2022-2025 | |
| Allergan, INC. | $452.51 | 2019-2021 | |
| Ocular Therapeutix, INC. | $273.34 | 2023-2025 | Dextenza |
| Aerie Pharmaceuticals, INC. | $225.75 | 2019-2021 | |
| Alcon Vision LLC | $221.49 | 2019-2025 | Clareon, Rocklatan, Tryptyr |
| Oyster Point Pharma, INC. | $103.05 | 2022-2024 | Tyrvaya |
| Johnson & Johnson Surgical Vision, INC. | $101.28 | 2020-2024 | Tecnis Iol |
| Dompe US, INC. | $89.60 | 2025 | Oxervate |
| Glaukos Corporation | $68.78 | 2020 | |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Sun Pharmaceutical Industries INC. | $46.13 | 2019-2023 | Cequa |
| Harrow Eye, LLC | $27.77 | 2025 | |
| Kala Pharmaceuticals, INC. | $24.57 | 2022 | |
| Mallinckrodt Hospital Products INC. | $18.44 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.42 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $16.63 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.42 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Pace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.